Literature DB >> 27266698

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention.

Zrinko Prskalo1, Ivica Brizić2, Darko Markota1, Ivica Markota1, Mladen Boban3, Monika Tomic4, Boris Starcevic5.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is one of the most important issues in modern medicine due to its high mortality and prevalence. An early detection and prevention can reduce morbidity and mortality. Arterial stiffness is a potent and independent predictor of CAD. We aimed to investigate the arterial stiffness in CAD patients undergoing the coronary angiography. Also, we investigated a possible correlation between arterial stiffness and in-stent restenosis (ISR), an important limitation of percutaneous coronary intervention (PCI).
METHODS: The study included 160 patients undergoing coronary angiography, treated either with PCI or with CABG. The pulse wave velocity (PWV) and augmentation index (AIx) were measured by the Arteriograph.
RESULTS: PWV in the CAD group (12.24 ± 2.78 m/s) was significantly higher compared to the control group (8.27 ± 1.89 m/s). PWV in ISR and left main (LM) stenosis group (14.03 ± 3.15 and 13.89 ± 2.95 m/s) was significantly higher compared to the control and CAD groups. Peripheral and central AIx were significantly higher in CAD group (1.38 ± 30.63 % and 38.35 ± 15.52 %) than in control group (-11.35 ± 26.74 % and 26.91 ± 10.62 %). Patients with LM stenosis have significantly higher values of peripheral and central AIx (23.37 ± 23.77 % and 49.71 ± 12.02 %) than the CAD and ISR group.
CONCLUSIONS: The study confirmed a positive correlation between arterial stiffness measures, PWV and AIx, and CAD. Also, this study showed the correlation between PWV and ISR which can help to select more appropriate stent.

Entities:  

Keywords:  Coronary artery disease; Coronary restenosis; Vascular stiffness

Mesh:

Year:  2016        PMID: 27266698      PMCID: PMC4895968          DOI: 10.1186/s12872-016-0305-4

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


Background

Coronary artery disease (CAD) is one of the most important issues in modern medicine due to high prevalence and mortality. Both, the prevention and treatment of CAD in recent decades have been improved, however, CAD remains the first inductor of morbidity and mortality in humans [1]. An early detection and prevention of CAD is very important and can reduce morbidity and mortality. Numerous epidemiological and clinical studies showed a positive correlation between CAD and male gender, high blood pressure, diabetes, smoking, physical inactivity, and hyperlipidemia [2]. In addition to these traditional risk factors, the arterial stiffness defined as a direct measure - aortic pulse wave velocity (PWV) and an indirect parameter - augmentation index (AIx), is a strong and independent predictor of CAD and adverse cardiovascular events [3, 4]. The majority of the current research, investigating correlation between arterial stiffness and CAD was of observational or epidemiological nature [5, 6]. Only few clinical studies showed a direct correlation between PWV and CAD diagnosed by coronary angiography [7, 8]. Treatment of CAD could involve pharmacotherapy, percutaneous coronary interventions (PCI), and surgical revascularization. All methods are associated with some limitations and disadvantages. In the past few decades the development of PCI, atherectomy, with bare-metal (BMS) and drug eluting stents (DES) has made a significant progress in the management of CAD [1]. The most important limitation of PCI is thrombosis and in-stent restenosis (ISR). The incidence of ISR after a BMS implantation is 20–25 % in the first 6 months [9]. The development of DES contributed to a significant reduction of the ISR, as it decreased the incidence rate of ISR in only 5–10 % cases [10-12]. However, the rate of DES use is lower than 10 % in most countries due to the high cost. The incidence of DES implantation in developing countries, such as ours, is smaller than an average rate, because of its higher cost. Factors that contribute to ISR are not fully understood. Cassese et al. showed that diabetes mellitus, multiple lesions, small vessels, multiple stents, smaller final stent lumen diameter and stent design are predictors for ISR [11, 13]. Some previous studies established a link between arterial stiffness and ISR. Ueda et al. found a correlation between AIx in the ascending aorta and ISR [14]. Also, Nakayama et al. showed a correlation between pulse pressure and ISR [15]. Recently, Mahfouz et al. described a correlation between arterial stiffness measured with ultrasonography and ISR [16]. In this study we aimed to investigate the correlation between CAD assessed by coronary angiography graded by SYNTAX score and arterial stiffness measured by Arteriograph, a simple, inexpensive, reproducible and investigator-independent method. Also, we investigated the correlation between ISR and aortic PWV and Aix.

Methods

The study included 160 patients with CAD who underwent an elective coronary angiography in the Department of Invasive Cardiology of Clinical Hospital Mostar from 1st April 2014 to 1st October 2014. The control group consisted of 59 sex and age-matched healthy people. All subjects in the control group underwent the clinical examination, ECG, stress test, echocardiography, measuring of arterial stiffness and laboratory testing. All those subjects had a clear medical history. The CAD group excluded subjects with atrial fibrillation, acute coronary syndrome, and with significant valvular disease. All CAD patients had previous concordant non-invasive findings for CAD and experienced angina pectoris. They received an appropriate treatment (statines, beta blockers, ACE inhibitors and aspirin) in accordance with the guidelines for CAD [17]. Out of a total number of CAD patients, 102 were treated with PCI and 58 underwent heart surgery. During the next 6 months 23 patients had ISR in BMS. All patients who underwent PCI had dual antiplatelet therapy, aspirin and clopidogrel. The study was conducted in accordance with the Helsinki Declaration and approved by the Ethics Committee of the University Hospital Mostar. All subjects gave written informed consent to participate in this study.

Coronary angiography and SYNTAX score

All patients underwent routine coronary angiography using the Judkins technique on digitized coronary angiography equipment (Shimadzu, Kyoto, Japan). Coronary angiograms were computerized and assessed by two experienced angiographers who were blinded to the results of arterial stiffness measurements. A significant CAD was defined as at least 50 % or more stenosis. ISR was defined as >50 % diameter stenosis at the stent site. The SYNTX score is a semi-quantitative angiographic tool to determine the extent of CAD [18]. The algorithm contains of 12 questions referring to the coronary anatomy and total number and extent of coronary artery lesions. The SYNTAX score was calculated for each coronary lesion producing a ≥50 % luminal obstruction in vessels with a diameter of 1.5 mm or more. Patients were divided according to 2-year rates of major adverse coronary events as low (0–22), intermediate (23–32), and high (≥33) risk group. The SYNTAX score was calculated with a computer-based questionnaire program.

Measurements of arterial stiffness

Arterial stiffness was measured by an oscillometric non-invasive device Arteriograph (TensioMed, Budapest, Hungary). The device detects and processes oscillations on the upper-arm positioned cuff by a special high fidelity sensor during a complete occlusion of brachial artery. Simultaneously with the parameters of arterial stiffness (PWV (m/s) an AIx (%), the device also recorded systolic and diastolic blood pressures and heart rate [19]. Twenty-four hours prior to the examination subjects were asked to refrain from exercise, fruits, vegetables, dietary supplements, tea, alcoholic beverages, and caffeine containing foods. Also, 12 hours before measurement of arterial stiffness patients did not take any drugs. All experiments were carried out in a quiet, temperature controlled room maintained around 24 °C and were started at 8 a.m. The subjects had rested quietly for 15 min in the supine position before the measurement.

Statistics

Data are expressed as mean ± SD. Statistical analyses were performed using GraphPad Instat and GraphPad Prism (San Diego, CA USA). All variables were normalized before data statistical analyses on age, heart rate and blood pressure. One-way ANOVA test was used to evaluate changes in AIx and PWV. When statistical significance was reached by ANOVA (P <0.05), Bonferroni test was used for the post hoc analysis.

Results

In this study we investigated the association of arterial stiffness with CAD and correlation between degrees of CAD measured by SYNTAX score. We found a strong correlation between CAD and arterial stiffness, but no association between degrees of the CAD with the parameters of arterial stiffness. From CAD group we extracted CABG, PCI, left main (LM) stenosis and ISR groups. The general characteristics of control, CAD, ISR and LM stenosis groups are shown in Table 1. In the control and all experimental groups the male sex was dominant. Also, in the CAD, ISR and LM stenosis group, patients were slightly older with higher mean arterial pressure.
Table 1

General characteristics of control, CAD and ISR groups

Control group (n-58)CAD group (n-160)ISR group (n-23)LM stenosis group (n-9)
Age (year)59.5 ± 5.461.5 ± 4.862.1 ± 6.163.8 ± 8.4
Male n (%)43 (72.9)115 (71.7)22 (95.7)9 (100)
Female n (%)16 (27.1)45 (28.3)1 (4.3)0 (0)
Smoking n (%)21 (35.6)82 (51.3)8 (34.8)6 (66.6)
Cholesterol (mmol/L)5.59 ± 1.455.38 ± 1.335.06 ± 1.565.45 ± 1.73
LDL (mmol/L)3.84 ± 0.783.66 ± 0.513.58 ± 0.683.78 ± 1.44
HDL (mmol/L)1.02 ± 0.431.08 ± 0.251.13 ± 0.581.06 ± 0.29
Triglycerides (mmol/L)2.12 ± 0.911.92 ± 0.771.84 ± 0.981.79 ± 0.43
Heart rate (beats/min)65.7 ± 6.164.1 ± 4,265.1 ± 9,764.7 ± 8,9
Mean blood pressure (mm Hg)101.3 ± 5.6104.6 ± 6,5105.7 ± 8.9106.1 ± 9.6
Diabetes mellitus n (%)0.0 (0.0)25 (15.7)3 (13.0)0 (0)
Glucose blood level (mmol/L)5.17 ± 0.675.71 ± 1.738.23 ± 0.725.34 ± 0.89
Renal failure n (%)0.0 (0.0)6 (3.75)1 (4.3)1 (11,1)
Creatinine (μmol/L)94.22 ± 22.9698.30 ± 26.04143109.78 ± 32.12
SYNTAX scores25.27 ± 4.119.33 ± 6.936.78 ± 14.47
Multiple stents n (%)14 (16.1)4 (17.3)
Stent diameter (mm)3.01 ± 0.783.09 ± 0.93
Length of stent (mm)18.4 ± 0.5818.1 ± 2.42

Data are shown as mean value ± SD

CAD coronary artery disease, HDL low-density lipoprotein, ISR in-stent restenosis, LM left main, LDL high-density lipoprotein, SD standard deviation

General characteristics of control, CAD and ISR groups Data are shown as mean value ± SD CAD coronary artery disease, HDL low-density lipoprotein, ISR in-stent restenosis, LM left main, LDL high-density lipoprotein, SD standard deviation Aortic PWV in the CAD group (12.24 ± 2.78 m/s) was significantly higher compared to the control group (8.27 ± 1.89 m/s) (P <0.05). Also, PWV of an ISR and LM stenosis group (14.03 ± 3.15 and 13.89 ± 2.95 m/s) was significantly higher than in the control and CAD group (P <0.05) (Fig. 1).
Fig. 1

The values of aortic pulse wave velocity (PWV) in the control, coronary artery disease (CAD), in-stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD group

The values of aortic pulse wave velocity (PWV) in the control, coronary artery disease (CAD), in-stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD group The central AIx in the CAD, ISR and LM stenosis group (38.35 ± 15.52, 39.71 ± 13.97 and 49.71 ± 12.02 %, respectively) was significantly higher compared to the control group (26.91 ± 10.62 %) (P <0.05). Also, central AIx of an LM stenosis group was significantly higher than in the CAD and ISR group (P <0.05) (Fig. 2).
Fig. 2

The values of aortic augmentation index (AIx), expressed in percentages in the control, coronary artery disease (CAD), in stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD and ISR groups

The values of aortic augmentation index (AIx), expressed in percentages in the control, coronary artery disease (CAD), in stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD and ISR groups The peripheral AIx in the CAD, ISR and LM stenosis group (1.38 ± 30.63 and 4.09 ± 27.60 and 23.37 ± 23.77 %, respectively) was significantly higher compared to the control group (−11.35 ± 26.74 %) (P <0.05). Also, peripheral AIx of an LM stenosis group was significantly higher than in the CAD and ISR group (P <0.05) (Fig. 3).
Fig. 3

The difference between the brachial augmentation index (AIx) in control, coronary artery disease (CAD), in stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD and ISR groups

The difference between the brachial augmentation index (AIx) in control, coronary artery disease (CAD), in stent restenosis (ISR) and left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD and ISR groups The SYNTAX score was significantly higher in patients who were referred for CABG and patients with LM stenosis (34.62 ± 12.46 and 36.78 ± 16.47) compared to the PCI and ISR group (17.63 ± 9.77 and 19.33 ± 6.9) (P <0.05). Among patients treated with PCI and patients who underwent CABG we did not find a difference in the parameters of arterial stiffness (CABG vs PCI group; PWV 12.23 ± 2.93 vs 12.26 ± 2.68 m/s; central Aix 37.93 ± 14.36 vs 38.47 ± 15.39 %; peripheral AIx 1.35 ± 28.32 vs 1.57 ± 30.38 %) (Additional file 1).

Discussion

In this study we showed a positive correlation between arterial stiffness parameters and CAD proved with coronary angiography. Also, our study showed the correlation between PWV and ISR. Some previous studies showed the correlation between arterial stiffness and CAD [20-22]. In the most of them CAD was proved with non-invasive methods. Several studies demonstrated the correlation between CAD examined with coronary angiography and arterial stiffness. Liu et al. showed positive correlation between arterial stiffness measured by Sphygmocor and CAD proved with multi slice computed tomography coronary angiography [23]. Imanishi et al. concluded that high brachial–ankle PWV is an independent predictor for the presence of CAD, especially in men [24]. Contrary to our investigation, the arterial stiffness in the mentioned studies was proved with different devices and at different blood vessels or coronary artery disease was not identified at coronary angiography. Only one study investigated the correlation between CAD and PWV measured by Arteriograph. Similar to our study, they found the positive correlation between CAD examined with coronary angiography and arterial stiffness [7]. However, despite high differences between PWV and AIx in the control and CAD group, we also did not find the correlation between the CAD grades (defined by SYNTAX score) with PWV and AIx. But still, in this study we proved a correlation between arterial stiffness and left main stenosis. However, Cho et al. showed the correlation between AIx and the grade of CAD in patients aged less than 65 years, but not in the older ones [25]. The correlation was not found in patients above 65 years. In our opinion, it is not realistic to expect that even this method can determine the level of CAD. Also, the measuring of arterial elasticity is developed in order to asses an increased cardiovascular risk but some other specific methods should be used to confirm and prove CAD. Furthermore, we investigated a correlation between ISR and arterial stiffness. The correlation between PWV and ISR was found, but not between AIx and ISR. Arterial stiffness is strongly dependent on the balance of two major proteins, elastin and collagen [26]. Normally, there is a tightly regulated balance between synthesis and degradation of these two proteins. Therefore, if there is an increased collagen production and reduced degradation in the whole vascular system, arterial stiffness will be increased and more likely an ISR will occur [27]. After the stent insertion some inflammatory changes in the coronary artery wall such as endothelial degradation, macrophage infiltration and smooth muscle cell proliferation could occur. Also, the inflammation in arteries increases the extracellular matrix proteins and collagen synthesis contributing to the ISR [28, 29]. BMS causes neointimal hyperplasia after implantation and leads to ISR and reintervention in more than 20 % of patients by 6 months [10, 11]. Similarly to our study, Ueda et al. showed the correlation between aortic stiffness and restenosis after balloon angioplasty [30]. However, mechanisms including collagen turnover in ISR and restenosis after balloon angioplasty are different. Stenting causes an even greater increase in collagen accumulation compared with balloon angioplasty [28, 31, 32]. Accordingly, the same author showed the correlation between aortic AIx and ISR [14], although the correlation between Aix and ISR was not found in our study. Recently, Mahfouz et al. proved the association of ISR and arterial elasticity [16]. All studies that have found a correlation between the extent of ISR and arterial stiffness were performed with various devices and methods. All results can contribute to a better understanding of ISR and help to make a decision considering stent implantation. In the cases of high PWV and other risks factors for ISR a cardiologist may be guided to implant DES. Moreover, this could be very useful in a cath lab with limited finances.

Conclusion

Our results confirm the importance of measuring arterial elasticity in patients with CAD predisposition. Also, we have found that an elevated PWV is associated with ISR suggesting its measuring before the procedure which contributes for a better selection of the stent implant. This study confirms the value of Arteriograph in cardiovascular risk assessment as a broadly applicable method for screening the general population.

Abbreviations

ACE, angiotensin-converting-enzyme; AIx, augmentation index; BMS, bare-metal stent; CABG, coronary artery bypass graft; CAD, coronary artery disease; DES, drug eluting stent; ISR, in-stent restenosis; LAD, left anterior descending artery; LM, left main; PCI, percutaneous coronary intervention; PWV, pulse wave velocity
  32 in total

1.  Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  Y Nakayama; K Tsumura; N Yamashita; K Yoshimaru; T Hayashi
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

2.  Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  Hiroyasu Ueda; Yasunori Nakayama; Kei Tsumura; Kiyomichi Yoshimaru; Tomoshige Hayashi; Junichi Yoshikawa
Journal:  Am J Hypertens       Date:  2002-09       Impact factor: 2.689

3.  The timing of the reflected wave in the ascending aortic pressure predicts restenosis after coronary stent placement.

Authors:  Hiroyasu Ueda; Tomoshige Hayashi; Kei Tsumura; Kiyomichi Yoshimaru; Yasunori Nakayama; Junichi Yoshikawa
Journal:  Hypertens Res       Date:  2004-08       Impact factor: 3.872

Review 4.  Arterial stiffness as a risk factor for coronary artery disease.

Authors:  Josh Liao; John Farmer
Journal:  Curr Atheroscler Rep       Date:  2014-02       Impact factor: 5.113

5.  The relation of aortic stiffness and in-stent restenosis in patients undergoing percutaneous coronary stenting.

Authors:  Ragab A Mahfouz; Amr Abdulmoneim; Mohammed Abduo; Waleed Elawady
Journal:  Echocardiography       Date:  2012-12-10       Impact factor: 1.724

Review 6.  Perspectives of drug-eluting stents: the next revolution.

Authors:  Jeffrey W Moses; Nicholas Kipshidze; Martin B Leon
Journal:  Am J Cardiovasc Drugs       Date:  2002       Impact factor: 3.571

7.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

8.  Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment.

Authors:  Ick-Mo Chung; Herman K Gold; Stephen M Schwartz; Yuji Ikari; Michael A Reidy; Thomas N Wight
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094

9.  Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.

Authors:  Salvatore Cassese; Robert A Byrne; Tomohisa Tada; Susanne Pinieck; Michael Joner; Tareq Ibrahim; Lamin A King; Massimiliano Fusaro; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  Heart       Date:  2013-11-22       Impact factor: 5.994

10.  Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.

Authors:  Krzysztof Milewski; Aleksander Zurakowski; Jacek Pajak; Ewa Pajak-Zielinska; Lukasz Liszka; Piotr P Buszman; Jaroslaw Bis; Marcin Debinski; Pawel E Buszman
Journal:  Med Sci Monit       Date:  2010-01
View more
  8 in total

1.  Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.

Authors:  Komal Malik; Susana Diaz-Coto; Maria de la Asunción Villaverde; Pablo Martinez-Camblor; Annie Navarro-Rolon; Francisco Pujalte; Alejandro De la Sierra; Pere Almagro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-10-14

2.  Incremental prognostic value of aortic stiffness in addition to myocardial ischemia by cardiac magnetic resonance imaging.

Authors:  Yodying Kaolawanich; Thananya Boonyasirinant
Journal:  BMC Cardiovasc Disord       Date:  2020-06-11       Impact factor: 2.298

3.  The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease.

Authors:  Nejc Piko; Sebastjan Bevc; Radovan Hojs; Franjo Husam Naji; Robert Ekart
Journal:  BMC Cardiovasc Disord       Date:  2021-01-13       Impact factor: 2.298

4.  Functional versus morphological assessment of vascular age in patients with coronary heart disease.

Authors:  Tino Yurdadogan; Carolin Malsch; Kornelia Kotseva; David Wood; Rainer Leyh; Georg Ertl; Wolfgang Karmann; Lara Müller-Scholden; Caroline Morbach; Margret Breunig; Martin Wagner; Götz Gelbrich; Michiel L Bots; Peter U Heuschmann; Stefan Störk
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

5.  Long-Term Prognosis after Coronary Artery Bypass Grafting: The Impact of Arterial Stiffness and Multifocal Atherosclerosis.

Authors:  Alexey N Sumin; Anna V Shcheglova; Sergey V Ivanov; Olga L Barbarash
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

6.  Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study.

Authors:  Pedro Martínez-Ayala; Guillermo Adrián Alanis-Sánchez; Luz Alicia González-Hernández; Monserrat Álvarez-Zavala; Rodolfo Ismael Cabrera-Silva; Jaime Federico Andrade-Villanueva; Karina Sánchez-Reyes; Moisés Ramos-Solano; Diego Alberto Castañeda-Zaragoza; David Cardona-Müller; Sylvia Totsuka-Sutto; Ernesto Cardona-Muñoz; Carlos G Ramos-Becerra
Journal:  BMC Cardiovasc Disord       Date:  2020-10-07       Impact factor: 2.298

7.  Coronary artery disease and its impact on the pulsatile brain: A functional NIRS study.

Authors:  Hanieh Mohammadi; Thomas Vincent; Ke Peng; Anil Nigam; Mathieu Gayda; Sarah Fraser; Yves Joanette; Frédéric Lesage; Louis Bherer
Journal:  Hum Brain Mapp       Date:  2021-05-15       Impact factor: 5.038

Review 8.  Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk.

Authors:  Nejc Piko; Sebastjan Bevc; Robert Ekart; Tadej Petreski; Nina Vodošek Hojs; Radovan Hojs
Journal:  World J Diabetes       Date:  2021-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.